dorfmanmaster

BMRN ridiculous Morningstar analyst target price!

Long
NASDAQ:BMRN   BioMarin Pharmaceutical Inc.
Morningstar weekly highlights set Biomarin Pharmaceuticals with an amazing $119 fair price value (50% above current price).

  • Rating: 4 stars
  • Uncertainty rating: Medium
  • Moat: Narrow




Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.